Silencing of frataxin gene expression triggers p53- dependent apoptosis in human neuron-like cells

Human Molecular Genetics

Volumn 20, Issue 14, 2011, Pages 2807-2822

  Palomo, Gloria M ^a,b   Cerrato, Toñi ^a,b   Gargini, Ricardo ^a   Diaz Nido, Javier ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; FRATAXIN; LENTIVIRUS VECTOR; PROTEIN BAX; PROTEIN P53; PUMA PROTEIN; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FRIEDREICH ATAXIA; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENE TRANSFER; HUMAN; HUMAN CELL; LENTIVIRINAE; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RNA SEQUENCE; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE; FRIEDREICH ATAXIA; GENE SILENCING; HUMANS; IRON-BINDING PROTEINS; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 79959792756     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr187     Document Type: Article

References (64)

1. Pandolfo, M. (2009) Friedreich ataxia: the clinical picture. J. Neurol., 256, 3-8.
2. Schulz, J.B., Boesch, S., Burk, K., Durr, A., Giunti, P., Mariotti, C., Pousset, F., Schols, L., Vankan, P. and Pandolfo, M. (2009) Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat. Rev. Neurol., 5, 222-234.
3. Campuzano, V., Montermini, L., Molto, M.D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A. et al. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science, 271, 1423-1427.
4. Campuzano, V., Montermini, L., Lutz, Y., Cova, L., Hindelang, C., Jiralerspong, S., Trottier, Y., Kish, S.J., Faucheux, B., Trouillas, P. et al. (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum. Mol. Genet., 6, 1771-1780.
5. Pandolfo, M. and Pastore, A. (2009) The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J. Neurol., 256, 9-17.
6. Gakh, O., Bedekovics, T., Duncan, S.F., Smith, D.Y.T., Berkholz, D.S. and Isaya, G. (2010) Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly. J. Biol. Chem., 285, 38486-38501.
7. Schmucker, S., Argentini, M., Carelle-Calmels, N., Martelli, A. and Puccio, H. (2008) The in vivo mitochondrial two-step maturation of human frataxin. Hum. Mol. Genet., 17, 3521-3531.
8. Richardson, D.R., Huang, M.L., Whitnall, M., Becker, E.M., Ponka, P. and Rahmanto, Y.S. (2010) The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia. J. Mol. Med., 88, 323-329.
9. Santos, R., Lefevre, S., Sliwa, D., Seguin, A., Camadro, J.M. and Lesuisse, E. (2010) Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid. Redox Signal., 13, 651-690.
10. Jauslin, M.L., Wirth, T., Meier, T. and Schoumacher, F. (2002) A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum. Mol. Genet., 11, 3055-3063.
11. Sturm, B., Bistrich, U., Schranzhofer, M., Sarsero, J.P., Rauen, U., Scheiber-Mojdehkar, B., de Groot, H., Ioannou, P. and Petrat, F. (2005) Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity? J. Biol. Chem., 280, 6701-6708.
12. Wong, A., Yang, J., Cavadini, P., Gellera, C., Lonnerdal, B., Taroni, F. and Cortopassi, G. (1999) The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet., 8, 425-430.
13. Haugen, A.C., Di Prospero, N.A., Parker, J.S., Fannin, R.D., Chou, J., Meyer, J.N., Halweg, C., Collins, J.B., Durr, A., Fischbeck, K. et al. (2010) Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology. PLoS Genet., 6, e1000812.
14. Santos, M.M., Ohshima, K. and Pandolfo, M. (2001) Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm. Hum. Mol. Genet., 10, 1935-1944.
15. Calmels, N., Seznec, H., Villa, P., Reutenauer, L., Hibert, M., Haiech, J., Rustin, P., Koenig, M. and Puccio, H. (2009) Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen. BMC Neurol., 9, 46.
16. Lu, C., Schoenfeld, R., Shan, Y., Tsai, C., Hammock, B. and Cortopassi, G. (2009) Frataxin deficiency induces Schwann cell inflammation and death. Biochim. Biophys. Acta, 1792, 1052-1061.
17. Napoli, E., Morin, D., Bernhardt, R., Buckpitt, A. and Cortopassi, G. (2007) Hemin rescues adrenodoxin, heme a and cytochrome oxidase activity in frataxin-deficient oligodendroglioma cells. Biochim. Biophys. Acta, 1772, 773-780.
18. Zanella, I., Derosas, M., Corrado, M., Cocco, E., Cavadini, P., Biasiotto, G., Poli, M., Verardi, R. and Arosio, P. (2008) The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. Biochim. Biophys. Acta, 1782, 90-98.
19. Biedler, J.L., Helson, L. and Spengler, B.A. (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res., 33, 2643-2652.
20. Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Cena, V., Gallego, C. and Comella, J.X. (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem., 75, 991-1003.
21. Gimenez-Cassina, A., Lim, F. and Diaz-Nido, J. (2006) Differentiation of a human neuroblastoma into neuron-like cells increases their susceptibility to transduction by herpesviral vectors. J. Neurosci. Res., 84, 755-767.
22. Myers, T.A., Nickerson, C.A., Kaushal, D., Ott, C.M., Honer zu Bentrup, K., Ramamurthy, R., Nelman-Gonzalez, M., Pierson, D.L. and Philipp, M.T. (2008) Closing the phenotypic gap between transformed neuronal cell lines in culture and untransformed neurons. J. Neurosci. Methods, 174, 31-41.
23. Galluzzi, L., Aaronson, S.A., Abrams, J., Alnemri, E.S., Andrews, D.W., Baehrecke, E.H., Bazan, N.G., Blagosklonny, M.V., Blomgren, K., Borner, C. et al. (2009) Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ., 16, 1093-1107.
24. Nath, R., Raser, K.J., Stafford, D., Hajimohammadreza, I., Posner, A., Allen, H., Talanian, R.V., Yuen, P., Gilbertsen, R.B. and Wang, K.K. (1996) Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J., 319, 683-690.
25. Culmsee, C. and Mattson, M.P. (2005) p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun., 331, 761-777.
26. Simon, D., Seznec, H., Gansmuller, A., Carelle, N., Weber, P., Metzger, D., Rustin, P., Koenig, M. and Puccio, H. (2004) Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J. Neurosci., 24, 1987-1995.
27. Klionsky, D.J., Abeliovich, H., Agostinis, P., Agrawal, D.K., Aliev, G., Askew, D.S., Baba, M., Baehrecke, E.H., Bahr, B.A., Ballabio, A. et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy, 4, 151-175.
28. Yousefi, S., Perozzo, R., Schmid, I., Ziemiecki, A., Schaffner, T., Scapozza, L., Brunner, T. and Simon, H.U. (2006) Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol., 8, 1124-1132.
29. Sawada, Y., Kajiwara, G., Iizuka, A., Takayama, K., Shuvaev, A.N., Koyama, C. and Hirai, H. (2010) High transgene expression by lentiviral vectors causes maldevelopment of Purkinje cells in vivo. Cerebellum, 9, 291-302.
30. Fleming, J., Spinoulas, A., Zheng, M., Cunningham, S.C., Ginn, S.L., McQuilty, R.C., Rowe, P.B. and Alexander, I.E. (2005) Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors. Hum. Gene Ther., 16, 947-956.
31. Cossee, M., Puccio, H., Gansmuller, A., Koutnikova, H., Dierich, A., LeMeur, M., Fischbeck, K., Dolle, P. and Koenig, M. (2000) Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum. Mol. Genet., 9, 1219-1226.
32. Stehling, O., Elsasser, H.P., Bruckel, B., Muhlenhoff, U. and Lill, R. (2004) Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum. Mol. Genet., 13, 3007-3015.
33. Condo, I., Ventura, N., Malisan, F., Tomassini, B. and Testi, R. (2006) A pool of extramitochondrial frataxin that promotes cell survival. J. Biol. Chem., 281, 16750-16756.
34. Kakhlon, O., Manning, H., Breuer, W., Melamed-Book, N., Lu, C., Cortopassi, G., Munnich, A. and Cabantchik, Z.I. (2008) Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation. Blood, 112, 5219-5227.
35. Pianese, L., Busino, L., De Biase, I., De Cristofaro, T., Lo Casale, M.S., Giuliano, P., Monticelli, A., Turano, M., Criscuolo, C., Filla, A. et al. (2002) Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. Hum. Mol. Genet., 11, 2989-2996.
36. Tan, G., Napoli, E., Taroni, F. and Cortopassi, G. (2003) Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells. Hum. Mol. Genet., 12, 1699-1711.
37. Cimadamore, F., Curchoe, C.L., Alderson, N., Scott, F., Salvesen, G. and Terskikh, A.V. (2009) Nicotinamide rescues human embryonic stem cell-derived neuroectoderm from parthanatic cell death. Stem Cells, 27, 1772-1781.
38. Saretzki, G., Walter, T., Atkinson, S., Passos, J.F., Bareth, B., Keith, W.N., Stewart, R., Hoare, S., Stojkovic, M., Armstrong, L. et al. (2008) Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells. Stem Cells, 26, 455-464.
39. Kim, H., Tu, H.C., Ren, D., Takeuchi, O., Jeffers, J.R., Zambetti, G.P., Hsieh, J.J. and Cheng, E.H. (2009) Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell, 36, 487-499.
40. Uo, T., Kinoshita, Y. and Morrison, R.S. (2007) Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons. J. Neurosci., 27, 12198-12210.
41. Wyttenbach, A. and Tolkovsky, A.M. (2006) The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons. J. Neurochem., 96, 1213-1226.
42. Xiang, H., Kinoshita, Y., Knudson, C.M., Korsmeyer, S.J., Schwartzkroin, P.A. and Morrison, R.S. (1998) Bax involvement in p53-mediated neuronal cell death. J. Neurosci., 18, 1363-1373.
43. Armstrong, J.S., Khdour, O. and Hecht, S.M. (2010) Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. FASEB J., 24, 2152-2163.
44. Torgovnick, A., Schiavi, A., Testi, R. and Ventura, N. (2010) A role for p53 in mitochondrial stress response control of longevity in C. elegans. Exp. Gerontol., 45, 550-557.
45. Guccini, I., Serio, D., Condo, I., Rufini, A., Tomassini, B., Mangiola, A., Maira, G., Anile, C., Fina, D., Pallone, F. et al. (2011) Frataxin participates to the hypoxia-induced response in tumors. Cell Death Dis., 2, e123.
46. Vosler, P.S., Brennan, C.S. and Chen, J. (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol. Neurobiol., 38, 78-100.
47. Esteves, A.R., Arduino, D.M., Swerdlow, R.H., Oliveira, C.R. and Cardoso, S.M. (2010) Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology. Neurobiol. Dis., 37, 723-730.
48. Oka, S., Ohno, M., Tsuchimoto, D., Sakumi, K., Furuichi, M. and Nakabeppu, Y. (2008) Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J., 27, 421-432.
49. Al-Mahdawi, S., Pinto, R.M., Ismail, O., Varshney, D., Lymperi, S., Sandi, C., Trabzuni, D. and Pook, M. (2008) The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum. Mol. Genet., 17, 735-746.
50. Navarro, J.A., Ohmann, E., Sanchez, D., Botella, J.A., Liebisch, G., Molto, M.D., Ganfornina, M.D., Schmitz, G. and Schneuwly, S. (2010) Altered lipid metabolism in a Drosophila model of Friedreich's ataxia. Hum. Mol. Genet., 19, 2828-2840.
51. Kroemer, G. and Levine, B. (2008) Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell. Biol., 9, 1004-1010.
52. Williams, A., Sarkar, S., Cuddon, P., Ttofi, E.K., Saiki, S., Siddiqi, F.H., Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P. et al. (2008) Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol., 4, 295-305.
53. Eisenberg-Lerner, A., Bialik, S., Simon, H.U. and Kimchi, A. (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ., 16, 966-975.
54. Lee, Y. and McKinnon, P.J. (2009) Detection of apoptosis in the central nervous system. Methods Mol. Biol., 559, 273-282.
55. Ristow, M., Mulder, H., Pomplun, D., Schulz, T.J., Muller-Schmehl, K., Krause, A., Fex, M., Puccio, H., Muller, J., Isken, F. et al. (2003) Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J. Clin. Invest., 112, 527-534.
56. Lim, F., Palomo, G.M., Mauritz, C., Gimenez-Cassina, A., Illana, B., Wandosell, F. and Diaz-Nido, J. (2007) Functional recovery in a Friedreich's ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector. Mol. Ther., 15, 1072-1078.
57. Laposa, R.R., Huang, E.J. and Cleaver, J.E. (2007) Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice. Proc. Natl Acad. Sci. USA, 104, 1389-1394.
58. D'Amelio, M., Cavallucci, V. and Cecconi, F. (2010) Neuronal caspase-3 signaling: not only cell death. Cell Death Differ., 17, 1104-1114.
59. Follenzi, A. and Naldini, L. (2002) HIV-based vectors. Preparation and use. Methods Mol. Med., 69, 259-274.
60. Sanchez, C., Diaz-Nido, J. and Avila, J. (1995) Variations in in vivo phosphorylation at the proline-rich domain of the microtubule-associated protein 2 (MAP2) during rat brain development. Biochem. J., 306, 481- 487.
61. Mattson, M.P., Barger, S.W., Begley, J.G. and Mark, R.J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell. Biol., 46, 187-216.
62. Degtyarev, M., De Maziere, A., Orr, C., Lin, J., Lee, B.B., Tien, J.Y., Prior, W.W., van Dijk, S., Wu, H., Gray, D.C. et al. (2008) Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J. Cell. Biol., 183, 101-116.
63. Mukhopadhyay, P., Rajesh, M., Hasko, G., Hawkins, B.J., Madesh, M. and Pacher, P. (2007) Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat. Protoc., 2, 2295-2301.
64. Domingo-Gil, E. and Esteban, M. (2006) Role of mitochondria in apoptosis induced by the 2-5A system and mechanisms involved. Apoptosis, 11, 725-738.